#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	15216	16S	1529	1529	99.93	16S.l6.c4.ctg.1	2101	718.3	0	.	n	.	0	C451T	SNP	451	451	C	672	672	T	904	T,C	454,403	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	15216	16S	1529	1529	99.93	16S.l6.c4.ctg.1	2101	718.3	1	SNP	n	C1184T	0	.	.	1184	1184	C	1405	1405	C	909	C	847	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	15216	16S	1529	1529	99.93	16S.l6.c4.ctg.1	2101	718.3	0	HET	.	.	.	C207T	.	207	207	C	428	428	C	895	C,T	660,176	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	28430	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3476	814.1	0	.	n	.	0	T695C	SNP	695	695	T	1001	1001	C	848	C	798	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	28430	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3476	814.1	0	.	n	.	0	A1638G	SNP	1638	1638	A	1944	1944	G	892	G,A,T	436,404,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	28430	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3476	814.1	0	.	n	.	0	T1971C	SNP	1971	1971	T	2277	2277	C	892	C	833	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	28430	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3476	814.1	1	SNP	n	A2045G	0	.	.	2045	2045	A	2351	2351	A	846	A	804	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	28430	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3476	814.1	1	SNP	n	C2597T	0	.	.	2597	2597	C	2903	2903	C	882	C	839	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_Y_01480c	folP.WHO_Y_01480c	1	1	27	2022	folP	855	855	100.0	folP.l15.c4.ctg.1	1503	133.7	1	SNP	p	R229S	1	.	.	685	687	AGC	956	958	AGC	191;190;192	A;G;C	181;179;180	folP.WHO_Y_01480c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5594	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3487	159.9	1	SNP	p	S91F	1	.	.	271	273	TTC	630	632	TTC	196;193;190	T;T;C	186;186;182	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5594	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3487	159.9	1	SNP	p	D95G	1	.	.	283	285	GGC	642	644	GGC	188;188;185	G;G;C	177;177;177	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5594	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3487	159.9	1	SNP	p	G95N	0	.	.	283	285	GGC	642	644	GGC	188;188;185	G;G;C	177;177;177	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_O_01438	mtrR.WHO_O_01438	1	1	27	1694	mtrR	633	633	100.0	mtrR.l15.c30.ctg.1	1443	116.8	1	SNP	p	G45D	0	.	.	133	135	GGC	555	557	GGC	207;208;210	G;G;C	198;196;198	mtrR.WHO_O_01438:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	884	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c4.ctg.1	953	92.2	0	.	n	.	0	A197.	DEL	197	197	A	546	546	A	213	A	196	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5800	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2915	198.1	1	SNP	p	D86N	0	.	.	256	258	GAC	575	577	GAC	239;241;242	G;A;C	224;221;225	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5800	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2915	198.1	1	SNP	p	R87W	0	.	.	259	261	CGT	578	580	CGT	240;238;241	C;G;T	228;225;223	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5800	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2915	198.1	1	SNP	p	S87R	1	.	.	259	261	CGT	578	580	CGT	240;238;241	C;G;T	228;225;223	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5800	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2915	198.1	1	SNP	p	R87I	0	.	.	259	261	CGT	578	580	CGT	240;238;241	C;G;T	228;225;223	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5800	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2915	198.1	1	SNP	p	S88P	0	.	.	262	264	TCC	581	583	TCC	244;245;245	T;C,G;C,T	229;229,1;228,1	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	4344	parE	1986	1986	100.0	parE.l15.c30.ctg.1	2721	159.0	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1541	1543	GGC	242;240;242	G;G;C	229;227;227	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.34.001	penA.34.001	1	1	27	4080	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2371	170.9	1	SNP	p	A311V	0	.	.	931	933	GCC	1169	1171	GCC	262;262;266	G;C;C	247;244;246	penA.34.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4080	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2371	170.9	1	SNP	p	I312M	1	.	.	934	936	ATG	1172	1174	ATG	265;266;270	A;T;G	246;246;251	penA.34.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4080	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2371	170.9	1	SNP	p	T316P	0	.	.	946	948	ACC	1184	1186	ACC	259;263;262	A;C;C	245;248;247	penA.34.001:1:1:T316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4080	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2371	170.9	1	SNP	p	V316T	1	.	.	946	948	ACC	1184	1186	ACC	259;263;262	A;C;C	245;248;247	penA.34.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4080	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2371	170.9	1	SNP	p	T483S	0	.	.	1447	1449	ACC	1685	1687	ACC	202;201;203	A;C;C	184;187;189	penA.34.001:1:1:T483S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4080	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2371	170.9	1	SNP	p	A501P	0	.	.	1501	1503	GCG	1739	1741	GCG	204;209;211	G;C;G	189;199;202	penA.34.001:1:1:A501P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4080	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2371	170.9	1	SNP	p	A501V	0	.	.	1501	1503	GCG	1739	1741	GCG	204;209;211	G;C;G	189;199;202	penA.34.001:1:1:A501V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4080	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2371	170.9	1	SNP	p	G542S	0	.	.	1624	1626	GGT	1862	1864	GGT	158;158;157	G;G;T	142;144;143	penA.34.001:1:1:G542S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4080	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2371	170.9	1	SNP	p	G545S	1	.	.	1633	1635	AGC	1871	1873	AGC	153;151;150	A;G;C	141;140;137	penA.34.001:1:1:G545S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4080	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2371	170.9	1	SNP	p	P551S	0	.	.	1651	1653	CCG	1889	1891	CCG	142;145;144	C,G;C;G	113,6;117;114	penA.34.001:1:1:P551S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	5868	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3048	191.7	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1598	1600	CCG	192;191;191	C;C;G,A	168;175;171,2	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2686	porA	1146	1146	99.91	porA.l6.c4.ctg.1	1722	154.9	0	.	p	.	0	M83fs	FSHIFT	247	247	A	519	519	C	167	C	156	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	27	2990	porB1b	1038	1038	100.0	porB1b.l15.c4.ctg.1	1594	186.3	1	SNP	p	G120K	1	.	.	358	360	AAG	708	710	AAG	233;233;238	A;A;G,T	211;218;217,1	porB1b.WHO_Y_02277c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	27	2990	porB1b	1038	1038	100.0	porB1b.l15.c4.ctg.1	1594	186.3	1	SNP	p	N121D	0	.	.	361	363	AAC	711	713	AAC	240;242;240	A;A;C	220;226;222	porB1b.WHO_Y_02277c:1:1:N121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	27	2990	porB1b	1038	1038	100.0	porB1b.l15.c4.ctg.1	1594	186.3	1	SNP	p	A121N	1	.	.	361	363	AAC	711	713	AAC	240;242;240	A;A;C	220;226;222	porB1b.WHO_Y_02277c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	10922	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	4911	222.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1256	rpsJ	312	312	100.0	rpsJ.l15.c17.ctg.1	1229	101.8	1	SNP	p	V57M	1	.	.	169	171	ATG	547	549	ATG	243;242;244	A;T;G	229;228;231	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
